What is the main business of Ivoclar-Vivadent Polska?

The main business activity of Ivoclar-Vivadent Polska focuses on wholesale of pharmaceutical goods.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on January 14, 2004.

Where is the headquarters located?

The headquarters is located at: Al. Jana Pawła Ii 78, 00-175 Warszawa.

Who is on the management board?

The management board consists of: Małgorzata Arabudzka (Member of the Management Board), Edyta Kalinowska (President of the Management Board), and Piotr Górski (Vice President of the Management Board).

What is the share capital?

The share capital of the company is PLN 2,170,000 (approx. $586,170).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.

What revenue was generated?

In 2025, the company generated total revenue of $17,154,419, representing an increase of 14.9% compared to 2024.

Is the company profitable?

Yes, the company recorded a net profit of $857,194 in 2025, meaning the company decreased its profit by 30.4%.

Which cost dominates operating expenses?

The largest operating cost category falls under cost of goods and materials sold. This category amounted to $13,005,902 in 2025, representing 81% of all operating expenses.

Ivoclar-Vivadent Polskasp. z o.o.

Wholesale of pharmaceutical goods

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2004-01-14

Share capital

2 170 000,00 PLN

Activity description

Ivoclar-Vivadent Polska is a company that offers dental solutions, including products like the Adhese® 2 adhesive, Tetric® plus composite, and PrograScan PS7 laboratory scanner. They also provide educational resources through the Ivoclar Academy for dental professionals. Additionally, they manufacture high-performance milling machines like the PrograMill PM7 and innovative materials for digital denture fabrication, such as Ivotion®.

Registered address

al. Jana Pawła II 78, 00-175 Warszawa, Poland

Website

ivoclar.com

Social media

Electronic delivery address

AE:PL-27271-53392-SCEJB-15

Financials

Revenue history (in m)

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue

This companyUSD 17.15mMedianUSD 873.84kAverageUSD 20.03m

Net profit

This companyUSD 857.19kMedianUSD 28.21kAverageUSD 815.54k

Operating costs

This companyUSD 16.06mMedianUSD 801.08kAverageUSD 18.78m

Assets

This companyUSD 5.37mMedianUSD 539.29kAverageUSD 10.66m

Industry

Bank accounts

Registered as a VAT taxpayer on 1996-01-01. Active

mBank
88 1140 1010 0000 2931 9000 1001
mBank
12 1140 1010 0000 2931 9000 1011
mBank
82 1140 1010 0000 2931 9000 1012

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

Public aid

4 public aid cases recorded, with a total value of $791,161.

Grant date	Purpose	Gross amount	Granting body
Jun 20, 2020	Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts Jun 20, 2020 · Prezes Zakładu Ubezpieczeń Społecznych	$9,826$9,826	Prezes Zakładu Ubezpieczeń Społecznych
May 30, 2020	Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts May 30, 2020 · Prezes Zakładu Ubezpieczeń Społecznych	$11,744$11,744	Prezes Zakładu Ubezpieczeń Społecznych
May 30, 2020	Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts May 30, 2020 · Prezes Zakładu Ubezpieczeń Społecznych	$11,603$11,603	Prezes Zakładu Ubezpieczeń Społecznych

Tenders

No recorded participation in tenders.

Regulatory authorisations

Authority	Type	Status
BDO	BDO register entry BDO	Active

Authorized Representatives

Małgorzata Arabudzka — Management Board Member

Edyta Kalinowska — President of the Management Board

Piotr Górski — Vice President of the Management Board

Manner of representation

Two members of the management board jointly are authorized to submit and sign declarations of will on behalf of the company.

Supervisory board

Michael Bickel — Supervisory Board Member

Martin Frontull — Supervisory Board Member

Markus Heinz — Supervisory Board Member

Ownership

Owner	Shares	Share value	Stake
Ivoclar Vivadent Ag	4,340	$586,169.64	100%

Beneficial owners

Person	Rights
Christoph Zeller (69)	100% udziałów w ze. wirtschaftstreuunternehmen incorporated in schaan, liechtenstein - 100% udziałów w ze. pharm trust reg. incorporated in schaan, liechtenstein - 100% udziałów w ivoclar vivadent ag. incorporated in schaan, liechtenstein - 100% udziałów w ivoclar-vivadent polska sp. z o.o.

Competitors

Name	Revenue	Website
Idalia Ludwikowscysp. j. Revenue: $41,868,843.38 · idalia.com.pl	$41,868,843.38	idalia.com.pl
APS Marcin WalasekS.K.A. Revenue: $37,508,581.19 · dentaltree.pl	$37,508,581.19	dentaltree.pl
Inter-VionS.A. Revenue: $28,169,315.92 · inter-vion.com	$28,169,315.92	inter-vion.com
VidisS.A. Revenue: $25,728,387.32 · vidis.pl	$25,728,387.32	vidis.pl
Sico Polskasp. z o.o. Revenue: $20,311,962.42 · sico.pl	$20,311,962.42	sico.pl
ProcadS.A. Revenue: $14,738,447.73 · procad.pl	$14,738,447.73	procad.pl
Pivexin Technologysp. z o.o. Revenue: $12,743,643.11 · pivexin-tech.pl	$12,743,643.11	pivexin-tech.pl
Eclipse Boluk-Sobolewskasp. k. Revenue: $10,235,697.61 · eclipsemedical.pl	$10,235,697.61	eclipsemedical.pl
ODA Medicalsp. z o.o. Revenue: $9,414,794.43 · odamedical.pl	$9,414,794.43	odamedical.pl
Medicavera Dahlhausen Groupsp. z o.o. Revenue: $7,393,838.95 · medicavera.pl	$7,393,838.95	medicavera.pl

Change history

Date	Event
2015-06-16	PKD change (Removed: 20.42.Z, 21.20.Z, 26.60.Z, 31.01.Z, 32.50.Z, 32.99.Z, 33.20.Z, 47.73.Z, 47.75.Z, 52.29.C, 72.19.Z, 73.11.Z, 73.12.A, 73.12.B, 73.12.C, 73.12.D, 85.32.A, 85.32.B, 85.51.Z, 85.52.Z; Added: 46.51.Z, 62.03.Z)
2010-05-31	PKD change (Removed: 24.42.Z, 24.52.Z, 33.10.A, 33.10.B, 51.46.Z, 51.70.B, 52.31.Z, 52.32.Z, 52.33.Z, 63.40.C, 73.10.F, 74.40.Z, 80.42.B, 85.13.Z; Added: 20.42.Z, 21.20.Z, 26.60.Z, 31.01.Z, 32.50.Z, 32.99.Z, 33.13.Z, 33.14.Z, 33.20.Z, 46.46.Z, 46.90.Z, 47.73.Z, 47.74.Z, 47.75.Z, 52.29.C, 72.19.Z, 73.11.Z, 73.12.A, 73.12.B, 73.12.C, 73.12.D, 74.90.Z, 85.32.A, 85.32.B, 85.51.Z, 85.52.Z, 85.59.B, 86.23.Z)
2004-01-14	Entered in the register

FAQ

Last updated: 2026-07-14